This new study identifies T cells associated with the autoimmune disease AAV

Published Date: 17 Feb 2023

Many patients with ANCA-associated autoimmune vasculitis (AAV) are at risk of disease recurrence despite treatment. Researchers at the Karolinska Institutet have just identified a T cell that contributes to the destruction of...

Read Full News

Latest News

Is Flare Prophylaxis Always Needed When Starting Gout Drugs?

There are divided opinions over whether anti-inflammatory drugs should always be used when initiating urate-lowering therapy for gout. Would a ‘pill in the pocket’ approach be better?

CMV Infection in Early Pregnancy Tied to Autism Risk in Kids

Children with congenital cytomegalovirus infection may experience complications such as autism and hearing loss if their mothers have a first-time infection during the first trimester.

Medicine Through Film: 10 Classics for Clinicians

Ten cinematic classics trace medicine’s moral, social, and scientific dilemmas — a curated watchlist that highlights storytelling, stigma, and a call for female leads.

Corticosteroids May Raise Risk for Mortality in IPF

The use of corticosteroids is linked to a higher risk for mortality in patients with acute exacerbations of idiopathic pulmonary fibrosis.

Mollicute Screening Improves Outcomes After Lung Transplant

Donor-recipient RNA assay significantly reduced the days to diagnosis of infection.

Hung Up on Hantavirus? How to Answer If Patients Are Asking

Recent outbreak on a Dutch cruise ship poses no risk to public at large, experts say.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Latest News

There are divided opinions over whether anti-inflammatory drugs should always be used when initiating urate-lowering therapy for gout. Would a ‘pill in the pocket’ approach be better?

Children with congenital cytomegalovirus infection may experience complications such as autism and hearing loss if their mothers have a first-time infection during the first trimester.

Ten cinematic classics trace medicine’s moral, social, and scientific dilemmas — a curated watchlist that highlights storytelling, stigma, and a call for female leads.

The use of corticosteroids is linked to a higher risk for mortality in patients with acute exacerbations of idiopathic pulmonary fibrosis.

Donor-recipient RNA assay significantly reduced the days to diagnosis of infection.

Recent outbreak on a Dutch cruise ship poses no risk to public at large, experts say.

News All Time

Why Quality Health Information May Drive Health Outcomes

Widespread use of online medical content and AI tools is reshaping decision-making and raising concerns about misinformation.

Inosine Pranobex Linked to Lower Mortality Risk in COVID

The use of inosine pranobex is associated with a lower risk for mortality in patients with COVID, a new study suggests.

EMA Greenlights Drugs for MS and Spinal Muscular Atrophy

Cenrifki prevents MS disease progression and Itvisma delivers a healthy gene-to-cell nuclei, addressing the root cause of SMA.

Bipolar II Disorder May Raise the Risk for Mortality

Bipolar II disorder is associated with higher all-cause mortality risk in teens and adults than bipolar disorder I or not having either condition, a new study shows.

Loneliness and Isolation: The Hidden Costs of Hospitalization

Adults who are hospitalized often feel lonely and socially isolated.

How Caring Differently Eases GP Stress Levels

GPs with a patient-centred orientation may experience lower perceived stress, whereas those with a higher number of daily patient contacts may experience higher stress.

UK Lawmakers Approve Lifetime Smoking Ban for Today's Under-18s

Children in Britain who are 17 or younger, and anyone born in the future, will never be able to ⁠legally buy cigarettes after lawmakers approved new stricter restrictions on...

COVID’s Cicada Invasion Doesn’t Yet Prompt Concerns

A previously dormant variant appears to evade the current vaccine, but impact remains unclear.

Crumbling NHS Hospitals to Face More Years of Risk and Cost

Seven hospitals with dangerous RAAC concrete won't be replaced until 2032-2033, costing up to £140 million extra per year of delay.

Fast-spreading Measles Outbreak Has Killed At Least 30 in Bangladesh, WHO Says

Bangladesh has confirmed 30 deaths in a measles outbreak that has spread ⁠rapidly across the country, with most of the victims aged under two, the World Health ⁠Organization...

Digital Twin Platform Comes to Orthopedics to Optimize Care

The platform will be used to build virtual anatomic replicas of patients to run simulations and plan surgery, make intraoperative decisions, and predict outcomes across treatment options.

NP-Led Clinic Boosts Care for Chronic Kidney Disease

A nurse practitioner-led clinic for chronic kidney disease improves clinical outcomes and increases the use of guideline-directed therapies and patient satisfaction, a study shows.

Recurring UTIs? Should Cranberry Products Be Recommended?

Evidence supports cranberry for the prevention, not treatment, of urinary tract infections, with standardized dosing critical to clinical benefit.

Analysis-COVID Shots, Newer Vaccines in Limbo After US Court Halts Kennedy’s Advisory Panel

Americans may face the next respiratory disease season without clear guidance for COVID shots and updated flu vaccines after a federal court ruling last month left several...

ACP Updates Guidance on Breast Cancer Screening

‘Sensible’ recommendations support biennial screening from age 50 to 74, with individualized decision-making for women below or above these age thresholds.

Hamilton Conservation Authority to Accept Nature Prescriptions

Hamilton Conservation Authority Joins PaRx, providing prescribers with a new strategy to improve health outcomes: nature.

Recommended News For You

Launch of the hereditary cancer clinic for precision oncology at Kokilaben Hospital.

Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL

What Caused a Man to Develop Friable Bleeding Nodules on His Arms and Hips?

Spicy Chip Death Lawsuit; Gen X and Cancer; Extreme U.S. Temperatures

Sarah Ferguson was identified as having malignant melanoma. These are the most recent therapies.

Scientists Employ Technology to Identify Plagiarism and Forgeries in Published Studies.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

Recommended Articles For You

Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine 

Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon  

The Capmist DM: A Revolutionary Way to Combat Dry Mouth 

Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In a study, immune detection of oral cancers is linked to obesity.

2.

Why breast cancer survivors don't take their medicine, and what can be done about it.

3.

Researchers have determined that malignancy hibernation will be the next front in the fight against breast cancer.

4.

finding fresh approaches to treating diffuse midline gliomas.

5.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

1.

Understanding Iron Saturation Levels in Your Blood 

2.

Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes

3.

The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review

4.

The Ultimate Guide to Understanding Abiraterone and its Uses in Cancer Treatment 

5.

The Truth About Marijuana and Its Effect on Mental Health 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

3.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

4.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias

5.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot